A review of the role of CSCs and CSC-EXOs in increasing drug resistance in breast cancer and future applications
- 22 May 2025
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 212, 104774
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Targeting breast cancer stem cells in ER-positive breast cancer by repurposing the benzoporphyrin derivative verteporfin as a YAP/TAZ small molecule inhibitorMolecular Biology Reports, 2025
- Breast cancer cell derived exosomes reduces glycolysis of activated CD8 + T cells in a AKT‐mTOR dependent mannerCell Biology International, 2024
- Microfluidic Biochips for Single‐Cell Isolation and Single‐Cell Analysis of Multiomics and ExosomesAdvanced Science, 2024
- Estrogen-related receptor alpha (ERRα) promotes the migration, invasion and angiogenesis of breast cancer stem cell-like cellsMedical Oncology, 2024
- Extracellular vesicles secreted by triple‐negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungsInternational Journal of Cancer, 2023
- Movement of Mitochondria with Mutant DNA through Extracellular Vesicles Helps Cancer Cells Acquire ChemoresistanceChemMedChem, 2021
- Cancer Stem Cell-Targeted Therapeutic Approaches for Overcoming Trastuzumab Resistance in HER2-Positive Breast CancerStem Cells, 2021
- Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces TumorigenicityStem Cell Reviews and Reports, 2020
- CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and TherapyAdvanced Biosystems, 2018
- Role of stem cell derived exosomes in tumor biologyInternational Journal of Cancer, 2017